{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:58:38Z","timestamp":1781787518649,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","award":["PRIN 2008 PTB3HC_002"],"award-info":[{"award-number":["PRIN 2008 PTB3HC_002"]}]},{"name":"Centro di Studio e Ricerca \u201cQuality and Technology Assessment, Governance and Communication Strategies in Health Systems\u201d"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.intimp.2013.11.015","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T01:47:08Z","timestamp":1385430428000},"page":"169-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effects of opioid therapy on human natural killer cells"],"prefix":"10.1016","volume":"18","author":[{"given":"Giovanna","family":"Tabellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Borsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Benassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Patrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Ricotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Caimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Lanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Micheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Iorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Bettaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Rezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi F.","family":"Rodella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Parolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.11.015_bb0005","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.83.18.7114","article-title":"Involvement of brain opiate receptors in the immune-suppressive effect of morphine","volume":"83","author":"Shavit","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.11.015_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0028-3908(90)90096-A","article-title":"Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism","volume":"29","author":"Bayer","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2013.11.015_bb0015","first-page":"131","article-title":"Immunomodulatory effects of chronic morphine treatment: pharmacologic and mechanistic studies","volume":"96","author":"Bryant","year":"1990","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.intimp.2013.11.015_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/brbi.1994.1003","article-title":"Morphine-induced decreases in in vivo antibody responses","volume":"8","author":"Lockwood","year":"1994","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.intimp.2013.11.015_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3181\/00379727-142-36968","article-title":"Interferon inhibition by narcotic analgesics","volume":"142","author":"Hung","year":"1973","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.intimp.2013.11.015_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(97)00216-6","article-title":"Opiates and infection","volume":"83","author":"Risdahl","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/archsurg.1991.01410280056007","article-title":"Effect of morphine on growth of metastatic colon cancer in vivo","volume":"126","author":"Yeager","year":"1991","journal-title":"Arch Surg"},{"key":"10.1016\/j.intimp.2013.11.015_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.cdd.4402170","article-title":"NK cells at the interface between innate and adaptive immunity","volume":"15","author":"Moretta","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.intimp.2013.11.015_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-065X.2008.00660.x","article-title":"Negative signaling by inhibitory receptors: the NK cell paradigm","volume":"224","author":"Long","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.intimp.2013.11.015_bb0060","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0065","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1073\/pnas.0409872102","article-title":"Characterization of CD56\u2212\/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals","volume":"102","author":"Mavilio","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.11.015_bb0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.11.015_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.192.3.337","article-title":"X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein\u2013Barr virus-infected cells","volume":"192","author":"Parolini","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.11.015_bb0080","first-page":"1112","article-title":"Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates","volume":"269","author":"Pacifici","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2013.11.015_bb0085","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/00000539-200006000-00028","article-title":"The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients","volume":"90","author":"Sacerdote","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.intimp.2013.11.015_bb0090","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","article-title":"Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study","volume":"121","author":"Sacerdote","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.intimp.2008.11.006","article-title":"Small doses of morphine can enhance NK cell cytotoxicity in pigs","volume":"9","author":"Borman","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0100","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0006-2952(80)90431-1","article-title":"Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes","volume":"29","author":"Lopker","year":"1980","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0105","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.125.6.2539","article-title":"Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes","volume":"125","author":"McDonough","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0110","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/0024-3205(87)90601-1","article-title":"Immunosuppressive effects of chronic morphine treatment in mice","volume":"41","author":"Bryant","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.intimp.2013.11.015_bb0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jneuroim.2003.10.029","article-title":"Immune, neuroendocrine, and somatic alterations in animal models of human heroin abuse","volume":"147","author":"Weber","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0120","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0889-1591(87)90034-1","article-title":"Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity","volume":"1","author":"Shavit","year":"1987","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.intimp.2013.11.015_bb0125","first-page":"341","article-title":"Opiate receptor mediated regulation of the immune response in vivo","volume":"76","author":"Weber","year":"1987","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.intimp.2013.11.015_bb0130","first-page":"1071","article-title":"Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone","volume":"265","author":"Lysle","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2013.11.015_bb0135","first-page":"1246","article-title":"Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking","volume":"272","author":"Flores","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2013.11.015_bb0140","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.6691146","article-title":"Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity","volume":"223","author":"Shavit","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.intimp.2013.11.015_bb0145","first-page":"693","article-title":"Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice","volume":"269","author":"Carr","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2013.11.015_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.intimp.2013.11.015_bb0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0165-5728(02)00165-0","article-title":"The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats","volume":"129","author":"Gaspani","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00540-004-0247-3","article-title":"Addition of noradrenaline to intrathecal morphine augments the postoperative suppression of natural killer cell activity","volume":"18","author":"Yokota","year":"2004","journal-title":"J Anesth"},{"key":"10.1016\/j.intimp.2013.11.015_bb0165","first-page":"287","article-title":"Effects of anesthetics and analgesics on natural killer cell activity","volume":"77","author":"Welden","year":"2009","journal-title":"AANA J"},{"key":"10.1016\/j.intimp.2013.11.015_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0192-0561(99)00025-9","article-title":"Effects of fentanyl on cellular immune functions in man","volume":"21","author":"Jacobs","year":"1999","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.intimp.2013.11.015_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1213\/00000539-200201000-00018","article-title":"Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans","volume":"94","author":"Yeager","year":"2002","journal-title":"Anesth Analg"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913004669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913004669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T11:10:20Z","timestamp":1688814620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913004669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1567576913004669"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.11.015","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of opioid therapy on human natural killer cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}